CLINICAL_TRIALS
withdrawal
· 2025-10-16
Clinical Trial Update: A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia [Phase 1, Phase 2]
Summary
A Phase 1/2 study evaluating pancreatic endocrine cell clusters implanted into the omentum for Type 1 diabetes patients with severe hypoglycemia has been withdr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seraxis | Conditions: Diabetes Mellitus Type 1 | Phase 1, Phase 2 | Status: WITHDRAWN